If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.685    0.065 (1.41%)
Bid:
4.70
Ask:
4.725
Spread: 0.025 (0.532%)
Market Cap: £224.86m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

Result of General Meeting

12 Jan 2017 08:15

RNS Number : 9910T
Seeing Machines Limited
12 January 2017
 

 

Seeing Machines Limited

("Seeing Machines" or the "Company")

Result of General Meeting

Total Voting Rights

Notification and Public Disclosure of Transactions by Persons Discharging Managerial Responsibilities

 

 

12 January 2017

Seeing Machines Limited (AIM: SEE), the AIM listed technology company with a focus on operator monitoring and intervention sensing technologies and services, is pleased to announce that, at its General Meeting held earlier today, the resolutions set out in the Notice of General Meeting sent to Shareholders on 16 December 2016, were duly passed.

Accordingly, it is expected that admission of the 329,611,500 Placing Shares and 45,388,500 Subscription Shares to trading on AIM will become effective at 8.00 a.m. 16 January 2017 ("Admission").

Following Admission, the Company will have 1,450,759,779 Ordinary Shares in issue. There are no shares held in treasury. The total voting rights will therefore be 1,450,759,779 and Shareholders may use this figure as the denominator for calculations by which they will determine whether they are required to notify their interest, or a change to their interest, in the ordinary share capital of the Company.

As announced on 19 December 2016, the Australian Offer and the Overseas Offer will close at 11.00 a.m. (AEDT) and 11.00 a.m. (GMT), respectively, on 19 January 2017. The results of the Offers will be announced shortly thereafter and admission of the ordinary shares to trading on AIM is expected to occur on 25 January 2017.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail of the number of Ordinary Shares purchased under the Subscription, for the beneficial interests of PDMR Ken Kroeger:

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Ken Kroeger

2.

Reason for the notification

a)

Position/status:

Chief Executive Officer

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Seeing Machines Limited

b)

LEI:

n/a

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

 

Identification code:

Ordinary Shares of nil consideration

 

AU0000XINAJ0

b)

Nature of the transaction:

Subscription for shares

c)

Price(s) and volume(s):

 

Price(s)

Volume(s)

4 pence

388,500

d)

Aggregated information:

· Aggregated volume:

· Price:

Single transaction as in 4 c) above

Price(s)

Volume(s)

Total

4 pence

388,500

£15,540

e)

Date of the transaction:

16/01/2017

f)

Place of the transaction:

London Stock Exchange, AIM Market (XLON)

 

Terms defined in the announcement published by the Company on 13 December 2016 shall have the same meaning in this announcement unless the context requires otherwise.

 

Enquiries:

Seeing Machines Limited

www.seeingmachines.com / +61 2 6103 4700

Ken Kroeger, Managing Director and CEO

Ken.Kroeger@seeingmachines.com

Media inquiries

marketing@seeingmachines.com

 

finnCap Ltd, Broker for Seeing Machines

Ed Frisby / Emily Watts, Corporate Finance

+44 20 7220 0500

Joanna Scott, Corporate Broking

 

Newgate, Investment Communications for Seeing Machines

Bob Huxford

 

 

Adam Lloyd

Tel: +44 20 7653 9848 / Mob: +44 7469 154 806

Bob.huxford@newgatecomms.com

 

Tel: +44 20 7653 9842 / Mob: +44 7966 609 084

Adam.loyd@newgatecomms.com

 

About Seeing Machines

Seeing Machines, (AIM: SEE) is focused on operator monitoring and intervention sensing technologies and services. With more than 15 years of experience, Seeing Machines uses advanced detection and prevention safety assistance technologies to track eye and facial movement in order to monitor fatigue, drowsiness and distraction events, such as microsleeps, texting and cell phone use as they occur, while providing for a real-time intervention strategy, which improves operator, driver and environmental safety, preserves assets, and reduces risk. Seeing Machines' technology is used worldwide across the automotive, mining, transport and aviation industries; as well as many of the leading academic research groups and transportation authorities. Seeing Machines is headquartered in Australia and has offices in Tucson, Arizona and Mountain View, California. The Company counts Caterpillar, Electro Motive Diesel, Progress Rail, Boeing, Takata, SEMCo, and Eye Tracking Inc among its partners.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLIFITLAIFLID
Date   Source Headline
1st Jul 20267:00 amRNSConvertible Note refinancing update
18th Jun 20267:00 amRNSUS$31m expansion on existing Automotive program
15th Jun 20267:00 amRNSSeeing Machines wins two new Japanese OEM programs
12th May 20267:00 amRNSUS$3.8m Order for Guardian BdMS
6th May 20267:00 amRNSQ3 FY2026 Quarterly KPIs
20th Apr 202612:30 pmRNSHolding(s) in Company
10th Apr 20268:53 amRNSStatement re alleged cyber threat
27th Mar 20267:00 amRNSHalf-year Financial Report
24th Feb 20267:00 amRNS-RPublication of Investor Presentation
18th Feb 20267:00 amRNSTrading Update - H1 FY2026
13th Feb 20267:30 amRNSAppointment of Joint Broker
11th Feb 20267:00 amRNSQ2 FY2026 Quarterly KPIs
13th Jan 202612:00 pmRNS-R3D Cabin Perception Mapping breaks new ground
6th Jan 20267:00 amRNSAgreement
5th Jan 20267:00 amRNSHolding(s) in Company
5th Jan 20267:00 amRNS-R3D Cabin Perception Mapping to be unveiled at CES
2nd Jan 20267:00 amRNS-RSeeing Machines Announces Future Mobility Group
2nd Jan 20267:00 amRNS-RSeeing Machines Announces Future Mobility Group
17th Dec 20257:00 amRNS-RTechnical Paper Series - Intoxication launched
4th Dec 20257:00 amRNS-RSeeing Machines 2025 Guardian Insights Report
27th Nov 20257:00 amRNSResults of AGM
26th Nov 20257:30 amRNSJapanese Auto Award and Extended European Program
12th Nov 20257:05 amRNSQ1 FY2026 Quarterly KPIs
12th Nov 20257:00 amRNSGuardian order from US-based multinational company
6th Nov 20257:05 amRNS-RCollaboration with Magna milestone in China
3rd Nov 20257:00 amRNSBoard Changes
3rd Nov 20257:00 amRNSNotice of Annual General Meeting
30th Oct 20257:00 amRNSLATAM Distributor Orders 1,300 Guardian Units
29th Oct 20257:00 amRNSAdvanced Development Project with Japanese OEM
8th Oct 20257:00 amRNSUS$1.8m expansion order for Guardian BdMS
26th Sep 20257:00 amRNSExpanding Guardian prospects across Europe
25th Sep 20257:00 amRNSFY2025 Results and Annual Financial Report
24th Sep 20257:20 amRNSFirst Guardian contract through Mitsubishi
10th Sep 20257:05 amRNS-RSeeing Machines Launches Impairment Capability
10th Sep 20257:00 amRNSNotice of Results and Presentation
29th Aug 202510:10 amRNSDirector Dealing
21st Aug 20257:00 amRNSFY2025 Trading Update
5th Aug 20257:00 amRNSQ4 FY2025 Quarterly KPIs
30th Jun 20257:00 amRNSMitsubishi Electric Europe Guardian collaboration
27th Jun 20257:00 amRNSUS Guardian Gen 3 trial with Mitsubishi Electric
16th Jun 20258:59 amRNS$1.2 Million Agreement with Global Auto Leader
9th May 20252:31 pmRNSDirector dealing
1st May 20257:00 amRNSQ3 FY2025 Quarterly KPIs
29th Apr 20259:58 amRNSNotification of Major Holdings
8th Apr 20258:53 amRNSHoldings in Company
8th Apr 20257:00 amRNSDirector/PDMR Shareholding
4th Apr 20257:00 amRNSDirector dealing
2nd Apr 202511:00 amRNSLondon presentation for investors and analysts
2nd Apr 20257:00 amRNSDirector dealing
2nd Apr 20257:00 amRNSDirector dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.